Tagged cancer
Press Release
Stellar Speakers to Make Targeting Metabesity 2020 One of the Most Important Healthy Longevity Conferences of the Year
Congresswoman Donna Shalala to join leading scientists, developers, regulators, and policy/business decision-makers who are seeking to accelerate translation of major scientific discoveries into products that slow the aging process and onset of major chronic diseases. Read More
Press Release
APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer
APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology. Read More
![GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]](files/05/ef/8e9877e2c6bac925c7094571eeb6.jpg)
Press Release
ARTIDIS Gains Strong Momentum in 2019, Raising CHF 8.8 Million in Seed Financing
ARTIDIS AG ("ARTIDIS"), a privately held healthtech company, announced today the successful closure of a CHF 8.8 million seed financing in two rounds, securing early clinical validation and the next development phase towards market entry in 2021. Read More
Press Release
Netflix 'Weed the People' Trailblazer Tracy Ryan Launches Much Anticipated 'Saving Sophie' Podcast
Celebrities, world-leading Cancer specialists, & Doctors set to guest with podcast host effervescent thinker and devoted mother Tracy Ryan and her miraculous seven-year-old daughter, Sophie. The mother-daughter duo will share groundbreaking Cancer and cannabis healing revelations on star-studded informative podcast. Read More
Press Release
ARTIDIS Joins the TMC Accelerator Device Cohort to Ensure That Its Cancer Diagnostic and Therapeutic Optimization Innovation Gains Early Access to the US Market
ARTIDIS announces its successful integration in the highly competitive international Medical Device Cohort 2019 of the Texas Medical Center's (TMC) Innovation Institute. Read More
Press Release
New Drug Screening Tool for Cancer Research Comes to Market
Breakthrough bioengineered, decellularized Wharton's Jelly matrix platform facilitates precision in vitro targeting of cancer stem cells (CSCs). The Sanatela™ Matrix is a revolutionary, natural 3-D biomaterial that gives researchers a tool to cultivate and study stem cells, including cancer stem cells. This matrix tissue opens new research opportunities for the development of individualized cancer treatments in the lab and for High-Throughput Drug Screening applications by pharmaceutical and biotechnology companies. Read More
Press Release
Next Generation Sequencing Market to Hit $15 Billion by 2025: Global Market Insights Inc.
North America next generation sequencing market surpassed USD one billion in 2018 and is expected to register a lucrative CAGR from 2019 to 2025, driven by increasing prevalence of cancer and genetic diseases Read More
Press Release